Found: 22
Select item for more details and to access through your institution.
COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281068
- By:
- Publication type:
- Article
Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5236, doi. 10.1002/alz.13872
- By:
- Publication type:
- Article
Association Between Redlining and Spatial Access to Pharmacies.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2327315, doi. 10.1001/jamanetworkopen.2023.27315
- By:
- Publication type:
- Article
Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded Adalimumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2323398, doi. 10.1001/jamanetworkopen.2023.23398
- By:
- Publication type:
- Article
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2318145, doi. 10.1001/jamanetworkopen.2023.18145
- By:
- Publication type:
- Article
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2024, v. 24, n. 5, p. 693, doi. 10.1007/s40256-024-00671-3
- By:
- Publication type:
- Article
Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 573, doi. 10.1007/s40256-021-00476-8
- By:
- Publication type:
- Article
COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.834743
- By:
- Publication type:
- Article
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 6, p. 835, doi. 10.1215/03616878-10041219
- By:
- Publication type:
- Article
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 24, p. 2390, doi. 10.1001/jama.2023.21481
- By:
- Publication type:
- Article
314-OR: Racial/Ethnic and Geographic Variation in the Initiation of Antidiabetic Therapies in Medicare Enrollees with Newly Diagnosed Type 2 Diabetes (T2D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-314-OR
- By:
- Publication type:
- Article
1107-P: Trends of First-Line Antidiabetic Treatment among 2007-2017 Medicare Beneficiaries Newly Diagnosed with Type 2 Diabetes (T2D) and Their Determinants.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1107-P
- By:
- Publication type:
- Article
782-P: Machine Learning to Identify Diabetes Patients Initiating SGLT2i at High-Risk of Acute Kidney Injury.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-782-P
- By:
- Publication type:
- Article
1131-P: Clinical, Demographic, Provider, and Formulary Characteristics Associated with Initiation of a SGLT2i or GLP-1RA among Medicare Beneficiaries with Type 2 Diabetes on Prior Oral Agents: A Cohort Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1131-P
- By:
- Publication type:
- Article
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2249370, doi. 10.1001/jamanetworkopen.2022.49370
- By:
- Publication type:
- Article
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 11, p. e234091, doi. 10.1001/jamahealthforum.2023.4091
- By:
- Publication type:
- Article
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 6, p. e231430, doi. 10.1001/jamahealthforum.2023.1430
- By:
- Publication type:
- Article
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 5, p. 644, doi. 10.1002/pds.5206
- By:
- Publication type:
- Article
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12872-023-03614-z
- By:
- Publication type:
- Article
Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 7, p. 1, doi. 10.1371/journal.pmed.1004069
- By:
- Publication type:
- Article
Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 7, p. e209132, doi. 10.1001/jamanetworkopen.2020.9132
- By:
- Publication type:
- Article